We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ASRT market cap is 90.7M. The company's latest EPS is USD -3.4766 and P/E is -0.28.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 42.47M | 40.99M | 35.63M | 32.99M | 32.45M |
Operating Income | 13.81M | 12.66M | -245.8M | -49.74M | -4.34M |
Net Income | -3.48M | 8.47M | -279.54M | -57.38M | -4.51M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 229.5M | 106.28M | 111.01M | 156.23M | 152.07M |
Operating Income | -194.43M | -82.16M | 9.42M | 58.09M | -269.07M |
Net Income | -217.2M | -28.14M | -1.28M | 109.63M | -331.94M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 414.27M | 405.18M | 380.03M | 286.42M | 281.97M |
Total Liabilities | 163.61M | 150.91M | 187.16M | 148.42M | 147.47M |
Total Equity | 250.66M | 254.27M | 192.87M | 138M | 134.49M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 527.17M | 303.27M | 326.55M | 413.91M | 286.42M |
Total Liabilities | 469.21M | 247.76M | 224.13M | 188.19M | 148.42M |
Total Equity | 57.96M | 55.51M | 102.41M | 225.73M | 138M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 22.72M | 41.32M | 43.9M | 49.6M | 7.51M |
Investing | -105k | -808k | 3.34M | 3.1M | N/A |
Financing | -18.95M | -35.28M | -35.29M | -44.2M | -206k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 90.48M | -65.57M | 5.52M | 78.6M | 49.6M |
Investing | -1.48M | 512.8M | -18.53M | -42.67M | 3.1M |
Financing | -157.84M | -468.55M | 29.03M | -7.79M | -44.2M |
Market Cap | 90.7M |
Price to Earnings Ratio | -0.28 |
Price to Sales Ratio | 0.6 |
Price to Cash Ratio | 1.25 |
Price to Book Ratio | 0.66 |
Dividend Yield | - |
Shares Outstanding | 95.48M |
Average Volume (1 week) | 904.94k |
Average Volume (1 Month) | 929.64k |
52 Week Change | -24.00% |
52 Week High | 1.798 |
52 Week Low | 0.7324 |
Spread (Intraday) | 0.01 (0.8%) |
Company Name | Assertio Holdings Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.assertiotx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions